Mary Ludlam PhD
​
Founder & CEO
-
Established biopharma R&D group leader
-
Serial drug discovery technology innovator
-
Expertise in cell biology, high-throughput microscopy and computational analysis
-
Critical role in multiple oncology programs including block-buster FDA-approved medicines
Susana Abreu Ribeiro PhD
​
Associate Director
Paris Site Head
-
Development of state of the art technologies for complex cell biology
-
Expert in cell line engineering, live-cell microscopy and high-throughput CRISPR screening
-
Design and implementation of tools and technologies to profile multiple oncology pathways
Catherine Lacayo PhD
​
Associate Director
Platform Biology
-
Expert in probing dynamics & perturbations in diverse cell-based formats
-
Highly skilled in cell line engineering and quantitative live-cell microscopy
-
Broad assay development skillset encompassing mammalian & iPS cells applied to toxicity testing & disease modeling
